A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia (NCT00424372) | Clinical Trial Compass
CompletedPhase 3
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
Japan126 participantsStarted 2007-01-12
Plain-language summary
To evaluate the safety of the long-term use of pregabalin.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who completed the 13-week treatment of postherpetic neuralgia in Study A0081120.
* Patients must be able to understand and cooperate with study procedures and have signed a written informed consent prior to entering the study.
Exclusion Criteria:
* Patients who experienced serious adverse events in the preceding study (A0081120) that were determined by the investigator or the study sponsor to be causally related to the study medication.
* Patients exhibiting treatment non-compliance in the preceding study (A0081120)
What they're measuring
1
Summary of Adverse Events
Timeframe: 52 weeks
Trial details
NCT IDNCT00424372
SponsorPfizer's Upjohn has merged with Mylan to form Viatris Inc.